Bridgewater, NJ, United States of America

Qingjie Ding

USPTO Granted Patents = 21 


 

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 148(Granted Patents)


Location History:

  • Clifton, NJ (US) (2002 - 2005)
  • Bridgewater, NJ (US) (2004 - 2017)

Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Qingjie Ding - Innovator in Antiviral Compounds

Introduction

Qingjie Ding, based in Bridgewater, NJ, is a distinguished inventor known for his significant contributions in the field of antiviral compounds. With a remarkable portfolio of 21 patents, his work continues to advance medical research and pharmaceutical applications.

Latest Patents

Qingjie Ding’s latest patents focus on antiviral compounds with the potential to combat Hepatitis C Virus (HCV) infections. The inventions disclose compounds of Formula I, where the variables in Formula I are meticulously defined. Furthermore, he has also introduced pharmaceutical compositions that contain these compounds, along with methods for their use in both the prevention and treatment of HCV infection.

Career Highlights

Qingjie Ding is currently affiliated with Hoffmann-La Roche Inc., where he applies his innovative skills to develop groundbreaking antiviral therapies. His commitment to advancing healthcare through scientific inquiry is reflected in the success and impact of his inventions.

Collaborations

Throughout his career, Qingjie has worked alongside notable colleagues such as Nan Jiang and Allen John Lovey. These collaborations highlight the collective effort in the innovative processes that lead to impactful research and patents.

Conclusion

In summary, Qingjie Ding stands out as a prolific inventor in the realm of antiviral research. His contributions through a robust set of patents emphasize the importance of innovation in developing solutions for critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…